# Codex Execution Status

Last updated: 2026-07-30

## Whole-product completion

Estimated completion: **20%**

This estimate reflects working, tested product behavior rather than roadmap line-item count. V3 now has the Phase 0 baseline, core publication trust primitives, and a local end-to-end visible preview. It is not ready to replace V2.

## Completed milestones

- Phase 0 V2 baseline and parity evidence captured.
- Canonical formatting, type, lint, test, build, dependency, and CodeQL gates.
- Data trust, freshness, provenance, manifest, and publication contracts.
- Deterministic manifest evaluation with last-known-good behavior.
- Atomic immutable build publication.
- Atomic active-build selection and validated one-step rollback.

## Current milestone

**Phase 1 visible vertical slice**

The current branch connects a preserved real repository snapshot through:

1. strict input validation;
2. explicit full-coverage scoring with no silent renormalization;
3. deterministic construction with 12% position and 30% sector caps;
4. immutable manifest-backed publication;
5. active-build selection;
6. a responsive dashboard projection;
7. zero-cost-compatible preview packaging.

The implementation, complete CI gate, and private hosted preview are complete. This unit is awaiting pull-request review and merge.

## Remaining milestones

- Complete Phase 1 coverage-aware scoring behavior and lineage across all future data sources.
- Expand portfolio construction with configurable exact caps and broader regression/property coverage.
- Build the production-grade end-to-end ingestion and daily publication pipeline.
- Add all primary V3 user workflows, degraded states, accessibility checks, and browser smoke coverage.
- Add protected server-side API and AI capabilities without exposed secrets.
- Establish preview and production deployment operations, health checks, and rollback procedures.
- Deliver the immutable daily evidence layer, model cards, metric dictionary, drift, and maturity labels.
- Implement point-in-time historical controls, corporate actions, walk-forward evaluation, costs, and benchmarks.
- Accumulate prospective daily validation evidence.
- Complete release-gate certification, recovery testing, accessibility review, and operational documentation.
- Perform final V3 production cutover only with explicit authorization after all gates pass.

## Blockers

- No product blocker is active.
- Final V3 production cutover remains explicitly out of scope without user authorization.

## Test counts

- Vitest suite: 43 tests across 7 files pass.
- Rendered deployment artifact suite: 2 tests pass.
- Total automated tests: 45 pass.
- Current unit validation status: Prettier, typecheck, lint, tests, all workspace builds, artifact-integrity checks, and `npm audit --audit-level=high` pass.

## Deployment status

- V2 production: unchanged.
- V3 local preview: running and HTTP-verified.
- V3 hosted preview: deployed privately at <https://akribeia-v3-evidence-preview.akribeiainsights.chatgpt.site>.
- V3 production: not deployed.
- Cutover: not authorized and not attempted.

## Evidence status

- V2 baseline fixtures and native parity reports: preserved.
- V3 immutable preview build: generated locally with manifest, artifact hashes, provenance, model/schema versions, and active pointer.
- V3 hosted vertical-slice evidence: deployed from validated commit `a943c7588`.
- Published daily evidence history: not started.
- Historical validation: not started.
- Prospective validation: not started.

## Risks and assumptions

- The current visible slice uses a preserved repository snapshot, not a live market feed.
- The snapshot timestamp lacked an explicit timezone; the build recipe records it as UTC because its generation time aligns with the baseline commit chronology.
- Scoring requires all five weighted pillars; incomplete rows fail closed instead of being silently renormalized.
- Portfolio allocation is deterministic and cap-exact but intentionally simple; transaction costs and turnover are not yet modeled.
- Active pointer writes assume one publication coordinator; concurrent writers remain last-writer-wins.
- All displayed results are research evidence, not investment advice or performance guarantees.
